Serum Tryptase Concentration During General Anaesthesia With Rocuronium
Status:
Completed
Trial end date:
2014-05-15
Target enrollment:
Participant gender:
Summary
Rocuronium is a aminosteroid structured, non-depolarizing neuromuscular blocking agents
(NMB). Epidemiological data presents that the frequency of hypersensitivity reactions caused
by rocuronium have been increased. Determinations of serum tryptase concentrations are
interdisciplinary recommended in diagnosis of its adverse reactions. No studies have been
performed to explain specific role of rocuronium doses on serum tryptase values. The aim of
this study was to investigate the potential effect of rocuronium on serum tryptase
concentrations.